🇺🇸 FDA
Patent

US 10377695

Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

granted A61PA61P25/00

Quick answer

US patent 10377695 (Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/00